ORTHOWORLD correctly estimated the worldwide spine market at $11.1 billion in 2025, up 3.3% from $10.8 billion the year before. The United States accounted for $7.9 billion, up 3.4%.
Those numbers are real.
The story people hang on them is not.
The 3% Trap
“Slow-growth commodity” is what you get when you blend Medtronic’s mid-single-digit machine with every me-too screw and cage still fighting over the same posterior lumbar case.
Medtronic: $2.55B in spine revenue | +6.1%
Globus Medical: $2.25B in spine revenue | +5.7%
Together, they control close to 43% of the market.
J&J: $884M spine business | -5.4%
Drop J&J into the blender with a long tail of lookalike hardware, and the average comes out to 3%. That average is useful for a slide; it is a terrible strategy document. Averages hide the companies that are actually moving.
The Four Outperformers
1/ ATEC
Growth: Spine sales grew 26% to $622M (ORTHOWORLD data). Reported $764M in total revenue (+25%), with surgical revenue up 26% on 22% procedure-volume growth.
The Play: Sell a procedure, not a tray. PTP and LTP are not “another lateral cage”—they are a designed sequence: positioning, access, neuromonitoring, alignment, i...
